WNK1 promotes head and neck squamous cell carcinoma progression through activation of NF-κB signaling pathway.
Saved in:
| Title: | WNK1 promotes head and neck squamous cell carcinoma progression through activation of NF-κB signaling pathway. |
|---|---|
| Authors: | Chen RZ; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Li R; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Cheng BL; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Lu SB; The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China., Hu W; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Lin F; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Wen X; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Chen Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China., Wang YL; The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China., Zhang MT; The First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China., Hong XH; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China. hongxh@smu.edu.cn., Tang XR; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Avenue, Guangzhou, 510515, Guangdong, China. tangxran@163.com. |
| Source: | Discover oncology [Discov Oncol] 2025 Oct 06; Vol. 16 (1), pp. 1822. Date of Electronic Publication: 2025 Oct 06. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-025-03637-2 |
